US Stock MarketDetailed Quotes

IVBIY INNOVENT BIOLOGICS INC UNSPON ADS EACH REP 4 ORD SHS

Watchlist
  • 19.150
  • 0.0000.00%
15min DelayClose Nov 21 16:00 ET
7.80BMarket Cap-42841P/E (TTM)

INNOVENT BIOLOGICS INC UNSPON ADS EACH REP 4 ORD SHS Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Total revenue
36.21%6.21B
6.71%4.56B
11.08%4.27B
266.94%3.84B
1.05B
Operating revenue
36.21%6.21B
6.71%4.56B
11.08%4.27B
266.94%3.84B
--1.05B
Cost of revenue
22.05%1.14B
84.23%930.99M
30.32%505.34M
210.51%387.76M
124.88M
Gross profit
39.84%5.07B
-3.69%3.63B
8.92%3.76B
274.58%3.46B
922.65M
Operating expense
-3.68%5.98B
8.83%6.21B
63.03%5.7B
58.94%3.5B
2.2B
Selling and administrative expenses
12.40%3.85B
0.00%3.43B
92.73%3.43B
87.56%1.78B
--947.81M
-Selling and marketing expense
19.68%3.1B
-1.12%2.59B
95.41%2.62B
93.62%1.34B
--692.52M
-General and administrative expense
-10.20%750.28M
3.66%835.49M
84.50%806.01M
71.12%436.87M
--255.3M
Research and development costs
-22.42%2.23B
23.63%2.87B
25.44%2.32B
43.00%1.85B
--1.29B
Operating profit
64.79%-909.21M
-33.15%-2.58B
-4,468.83%-1.94B
96.68%-42.44M
-1.28B
Net non-operating interest income expense
303.25%354.21M
-1.63%87.84M
86.99%89.29M
10.51%47.75M
43.21M
Non-operating interest income
138.92%452.84M
24.90%189.54M
30.71%151.76M
13.05%116.1M
--102.7M
Non-operating interest expense
-3.02%98.62M
62.81%101.7M
-8.61%62.46M
14.89%68.35M
--59.49M
Other net income (expense)
Special income (charges)
-1,686.67%-952K
108.46%60K
40.92%-709K
---1.2M
--0
-Less:Other special charges
1,686.67%952K
-108.46%-60K
-40.92%709K
--1.2M
----
Other non- operating income (expenses)
-56.83%-680.09M
39.56%-433.64M
-86.80%-717.42M
23.15%-384.06M
---499.73M
Income before tax
47.27%-1.14B
17.84%-2.17B
-207.64%-2.64B
50.07%-858.71M
-1.72B
Income tax
-1,423.69%-116.5M
-89.89%8.8M
-37.70%87.04M
139.71M
0
Net income
52.83%-1.03B
20.14%-2.18B
-173.31%-2.73B
41.95%-998.42M
-1.72B
Net income continuous Operations
52.83%-1.03B
20.14%-2.18B
-173.31%-2.73B
41.95%-998.42M
---1.72B
Minority interest income
Net income attributable to the parent company
52.83%-1.03B
20.14%-2.18B
-173.31%-2.73B
41.95%-998.42M
-1.72B
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
Net income attributable to common stockholders
52.83%-1.03B
20.14%-2.18B
-173.31%-2.73B
41.95%-998.42M
-1.72B
Basic earnings per share
54.79%-2.64
22.34%-5.84
-154.05%-7.52
49.32%-2.96
-5.84
Diluted earnings per share
54.79%-2.64
22.34%-5.84
-154.05%-7.52
49.32%-2.96
-5.84
Dividend per share
Currency Unit
CNY
CNY
CNY
CNY
CNY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Total revenue 36.21%6.21B6.71%4.56B11.08%4.27B266.94%3.84B1.05B
Operating revenue 36.21%6.21B6.71%4.56B11.08%4.27B266.94%3.84B--1.05B
Cost of revenue 22.05%1.14B84.23%930.99M30.32%505.34M210.51%387.76M124.88M
Gross profit 39.84%5.07B-3.69%3.63B8.92%3.76B274.58%3.46B922.65M
Operating expense -3.68%5.98B8.83%6.21B63.03%5.7B58.94%3.5B2.2B
Selling and administrative expenses 12.40%3.85B0.00%3.43B92.73%3.43B87.56%1.78B--947.81M
-Selling and marketing expense 19.68%3.1B-1.12%2.59B95.41%2.62B93.62%1.34B--692.52M
-General and administrative expense -10.20%750.28M3.66%835.49M84.50%806.01M71.12%436.87M--255.3M
Research and development costs -22.42%2.23B23.63%2.87B25.44%2.32B43.00%1.85B--1.29B
Operating profit 64.79%-909.21M-33.15%-2.58B-4,468.83%-1.94B96.68%-42.44M-1.28B
Net non-operating interest income expense 303.25%354.21M-1.63%87.84M86.99%89.29M10.51%47.75M43.21M
Non-operating interest income 138.92%452.84M24.90%189.54M30.71%151.76M13.05%116.1M--102.7M
Non-operating interest expense -3.02%98.62M62.81%101.7M-8.61%62.46M14.89%68.35M--59.49M
Other net income (expense)
Special income (charges) -1,686.67%-952K108.46%60K40.92%-709K---1.2M--0
-Less:Other special charges 1,686.67%952K-108.46%-60K-40.92%709K--1.2M----
Other non- operating income (expenses) -56.83%-680.09M39.56%-433.64M-86.80%-717.42M23.15%-384.06M---499.73M
Income before tax 47.27%-1.14B17.84%-2.17B-207.64%-2.64B50.07%-858.71M-1.72B
Income tax -1,423.69%-116.5M-89.89%8.8M-37.70%87.04M139.71M0
Net income 52.83%-1.03B20.14%-2.18B-173.31%-2.73B41.95%-998.42M-1.72B
Net income continuous Operations 52.83%-1.03B20.14%-2.18B-173.31%-2.73B41.95%-998.42M---1.72B
Minority interest income
Net income attributable to the parent company 52.83%-1.03B20.14%-2.18B-173.31%-2.73B41.95%-998.42M-1.72B
Preferred stock dividends
Other preferred stock dividends 00000
Net income attributable to common stockholders 52.83%-1.03B20.14%-2.18B-173.31%-2.73B41.95%-998.42M-1.72B
Basic earnings per share 54.79%-2.6422.34%-5.84-154.05%-7.5249.32%-2.96-5.84
Diluted earnings per share 54.79%-2.6422.34%-5.84-154.05%-7.5249.32%-2.96-5.84
Dividend per share
Currency Unit CNYCNYCNYCNYCNY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data